Surgical management of dialysis-dependent ischemic nephropathy  by Hansen, Kimberley J. et al.
Surgical management 
ischemic nephropathy 
of dialysis-dependent 
Kimberley J. Hansen, MD, R. Bradley Thomason,  MD,  T imothy E. Craven, MSPH,  
Stanley B. Fuller, MD,  Donna R. Keith, AS, Richard G. Appel, MD, and 
Richard H.  Dean, MD,  Winston-Salem, N. C. 
Purpose: This retrospective r view describes urgical management of dialysis-dependent 
ischemic nephropathy. 
Methods: From February 1987 through September 1993, 340 patients underwent 
operative renal artery (RA) reconstruction atour center. A subgroup of 20 patients (6 
women; 14 men; mean age 66 years) dependent on hemodialysis immediately before KA 
repair form the basis of this report. Glomerular filtration rates (EGFR) were estimated 
from at least three serum creatinine measurements obtained 26 weeks before and after 
operation. A linear regression model was used to estimate the mean rate of change of 
EGFR before and after RA repair. Comparative analysis of kidney status and change in 
EGFR were performed. The influence of function response on follow-up survival was 
determined by the product-limit method. 
Results: Hemodialysis was discontinued in 16 of 20 patients (80%). For these 16 patients, 
postoperative EGFR ranged from 9.0 to 56.1 ml/min/1.73 m 2 (mean 32.4 ml/min]l.73 
m2). Two of 16 patients resumed hemodialysis 4 and 6 months after surgery. 
Discontinuation fdialysis was more likely after bilateral or complete RA repair (15 of 16 
patients) versus unilateral repair (one of four patients;p = 0.01). Permanent discontinu- 
ation of dialysis was associated with a rapid preoperative rate of decline in EGFR (mean 
slope log c EGFR: - 0.1393 + 0.0340 without dialysis; - 0.0188 --- 0.0464 with dialysis; 
p = 0.04, but NS after controlling for multiple comparisons). Immediate increase in 
EGFR after operation was inversely correlated with the severity of nephrosclerosis (rank 
correlation: -0.57; 95% confidence interval [ -0.83,  -0.10]). Follow-up death was 
associated with dialysis dependence; two deaths occurred among 14 patients not receiving 
dialysis, whereas five of six patients dependent on dialysis died (p < 0.01). 
Conclusion: Surgical correction of ischemic nephropathy can retrieve renal function in 
selected patients dependent on dialysis characterized by a rapid decline in preoperative 
EGFR in combination with global renal ischemia treated by complete or bilateral renal 
revaseularization. After RA repair, discontinuation of dialysis may be associated with 
improved survival rates when compared with continued dialysis dependence. (J VASC 
SURG 1995;21:197-211.) 
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Recent reports suggest hat atherosclerotic renovas- 
cular occlusive disease (RVD) may contribute to the 
development of  renal insufficiency3 "4 This relation- 
ship has been recognized by the term "ischemic 
nephropathy," which describes hemodynamically 
significant RVD in combination with excretory renal 
insufficiency. 4 Data to date suggest that ischemic 
nephropathy may be associated with renal dysfunc- 
tion, which is progressive, potentially leading to 
end-stage renal disease (ESRD). 3-5 Although previ- 
ous reports have indicated that renal function may be 
retrieved after correction of  RVD in selected patients 
dependent on dialysis, enthusiasm for renal revascu- 
larization in this clinical setting is varied.58 Acknowl- 
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Table I. Prevalence of associated extrarenal therosclerosis 
No. of Patients (%) Clinical Manifestations 
Cardiac 19 (95) Angina 12 
MI 13 
CABG 2 
LVH 19 
Cerebrovascular 9 (45) TIA 8 
CVA 5 
CEA 4 
Aortoiliac 16 (80) Severe occlusive disease 15 
Aortic occlusion 3
Aortic aneurysm 4 
At least one manifestation 20 (100) 
214/, Myocardial infarction; CABG, coronary artery bypass graft; LVH, left ventricular hypertrophy; T/A, transient ischemic attack; CVA, 
cerebrovascular accident; CEA, carotid endarterectomy. 
edging the increased perioperative mortality and 
morbidity rates in patients with end-stage renal 
insufficiency, the high prevalence of associated extra- 
renal atherosclerosis frequently requiting complex 
operative repair and the uncertain renal function 
response to revascularization, authors have cautioned 
against surgical management in these patients. 9 
By contrast, we continue to explore the natural 
history of ischemic nephropathy and the role of 
surgical intervention i  patients with renal insuffi- 
ciency of all severity. Consequently, we undertook 
this retrospective r view of operative management of 
dialysis-dependent ischemic nephropathy todescribe 
the rate of change in renal function before and after 
operation, to evaluate determinants of recovery of 
renal function, and, finally, to examine the influence 
of function recovery on patient survival. With respect 
to renal function response to surgery, specific hy- 
potheses of interest included (1) effect of site of 
disease and operation on function retrieval; (2) effect 
of preoperative rate of decline in renal function on 
function response to operation; (3) the effect of 
renovascular repair on postoperative rate of renal 
function deterioration. 
PATIENT DEMOGRAPHICS 
During the period from February 1, 1987 
through September 30, 1993, 340 patients had 
operative repair of RVD at the Wake Forest Univer- 
sity Medical Center. A subgroup of 20 consecutive 
patients dependent on dialysis from I to 9 weeks 
(mean 3.4 weeks) before surgery form the basis of 
this report. All patients were free of any recent event 
that could cause acute and spontaneously reversible 
kidney failure. In particular, patients with RVD and 
acute kidney failure requiring dialysis in combination 
with recent exposure to angiographic contrast mate- 
tial, hypotension, or angiotensin-converting e zyme 
inhibitors were omitted. The study group included 
six women and 14 men ranging in age from 51 to 81 
years (mean age 66 years). Seventeen ofthese patients 
(85%) were over the age of 60 years, and seven were 
in the eighth decade of life. 
Hypertension was present in each patient and 
ranged in duration from 1 to 57 years. Only three 
patients had had hypertension for less than 5 years. 
For the group, the highest known blood pressure 
within 3 months of operation ranged from 190/80 
mm Hg to 270/148 mm Hg (mean 224/110 mm 
Hg). Medical therapy for hypertension control be- 
fore operation ranged from three to six drugs (mean 
3.7 drugs). In addition to hypertension, other risk 
factors for atherosderosis ncluded cigarette use 
(95%), hyperlipidemia (25%), and diabetes mellitus 
(15%). Evidence of at least one extrarenal manifes- 
tation of site-specific atherosclerotic damage was 
present in all 20 patients (Table I). 
MATERIAL AND METHODS 
During this study period, all patients who had 
acceptable operative risk, significant hypertension, 
and dialysis-dependent ischemic nephropathy had 
surgical renal revascularization. Inclusion in this 
review required renal insufficiency requiring dialysis 
support before the time of operation in the absence 
of reversible causes of acute kidney failure. Each 
patient was considered end-stage and was believed to 
require permanent renal replacement therapy if 
function retrieval was not obtained by surgical 
intervention. Serum creatiuine measurements made 
at the initiation of dialysis support ranged from 6.6 
to 15.3 mg/dl (mean 8.8 mg/dl). In addition to these 
measurements, determinations of serum creatinine 
obtained during the 6-month period before and 
after operation were included in the database for 
analysis. 
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Data management and analysis 
Assessment of renal function. To account for 
between-subject differences in sex, age, and weight, 
all values of serum creatinine were transferred to a 
calculated measure of estimated glomerular filtration 
rate (EGFR, ml/min/1.73 m 2) with the following 
formula of Cockroft and Gault 1° as modified by Rolin 
et al)l: 
EGFR = (140 - Age) (Weight) 1.73 × -  
(72)(Serum creatinine) BSA 
where body surface area (BSA) was calculated with 
the following formula: BSA = [Height (cm)] °72s × 
[Weight (kg)! °42"~ x 0.007184. For female subjects, 
the EGFR was multiplied by 0.85 to correct for 
sex-related ifferences in muscle mass and average 
rate of creatinine synthesis. 
Applying this calculation to the last serum creat- 
inine measurements immediately before initiation of 
hemodialysis, EGFR ranged from 4.5 to 11.0 
ml/min/1.73 m 2 with a mean value of 7.7 
ml/min/1.73 m 2. 
Statistical methods and analysis. Summary 
statistics (i.e., means, standard deviations, etc., of 
continuous data, and frequencies and relative fre- 
quencies of categorical data) were calculated, and the 
data were examined to verify that assumptions of 
statistical tests were met. Postoperative survival 
distributions were estimated with use of the product- 
limit method. 12 Effects of postoperative dialysis 
dependence and other factors on survival were 
estimated and tested univariately with separate pro- 
portional hazards regression models. 13 
EGFR was calculated from serum creatinine as 
described above. Paired t tests were used to test the 
significance of the initial increase in renal function, 
estimated as the differences between the first post- 
operative and last predialysis EGFRs. For purposes 
of comparison, subjects who remained ependent on 
dialysis after operation were defined to have first 
postoperative EGFR equal to the last predialysis 
EGFR (i.e., a change of zero). In addition, the 
changes in EGFR before and after operation for these 
20 patients dependent on dialysis were compared 
with EGFR data from 53 consecutive patients with 
azotemia treated by the authors during the same 
study period. 4These latter patients were character- 
ized by a serum creatinine value of at least 1.8 mg/dl 
but without dialysis dependence before operation. 
Per week rates of deterioration i  EGFR were 
estimated by modeling the natural logarithm of 
EGFR [log e (EGFR)] as a linear ftmction of time in 
a general mL~ed effects regression model.~4 Estimates 
of mean deterioration rates (slopes) were obtained 
for preoperative and postoperative data via a random 
regression coefficients analysis, ls'16 In this analysis, 
parameters toestimate separate mean regression lines 
for preoperative and postoperative data were com- 
puted. The random coefficients analysis was per- 
formed by pooling data from all 73 subjects (20 
dependent on dialysis before operation and 53 not 
dependent on dialysis before operation). Between- 
group comparisons of mean slopes were made by 
defining linear contrasts of appropriate, estimated 
regression parameters. 17 MI estimates of decrease in 
EGFR were obtained for the period beginning 26 
weeks before dialysis and ending 26 weeks after 
surge U. Mean percentage changes in EGFR during 
the preoperative and postoperative periods for 
groups of patients were calculated with use of the 
following formula: mean percent per week 
decrease = 100 x (1 - e . . . . .  lope). 
Associations between selected preoperative fac- 
tors (nephrosclerosis grade, extent of extrarenal 
atherosclerosis, renal artery percent stenosis, renal 
length, and preoperative d terioration rate) and renal 
function response to operation were assessed with use 
of Pearson's product-moment correlations or Spear- 
man's rank correlation. Statistical tests for contin- 
gency table analysis of differences between groups 
were performed with Fisher's exact est. 
When making statistical inferences concerning 
difference in renal function response for patients with 
unilateral versus bilateral repairs and when compar- 
ing preoperative and postoperative deterioration 
rates in renal function responders and nonre- 
sponders, multiple hypotheses were tested under 
single (conceptual) experiment settings. To control 
for propagation ofexperimentwise type 1 error rates, 
Holm's sequentially rejective Bonferroni procedure 
was used. 18 The p values of pairwise tests less than 
0.05, which were not significant after controlling for 
the number of multiple comparisons, are noted in the 
tables and the text. When examining prospective cor- 
relates of immediate renal function response, 95% 
confidence intervals (CI) for the estimated correla- 
tion coefficients are presented rather thanp values. 
Definitions 
Renal function response to surgery. Immediate 
function response to surgery was defined by the 
calculated EGFR and need for maintenance dialysis 3 
weeks after operation. The patient was considered 
dependent on dialysis on follow-up if dialysis support 
was required beyond 3 weeks from the operative 
date. 
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Table II. Angiographic grade of nephrosclerosis (n = 26 kidneys) 
Severity of nephrosclerosis (%) 
Grade I 4 
Normal intrarenal vessels (no ectasia) 
Orderly progression of branching pattern (no pruning) 
Normal nephrogram with distinct corticomednllary junction 
Grade II 46 
Ectasia of arcuate and distal interlobar arteries 
Peripheral pruning 
Reduced arterial volume with normal renal mass 
Normal nephrogram 
Grade III 50 
Marked ectasia extending centrally 
Total pruning with abrupt interlobar artery terminations 
Marked reduced arterial volume with decreased renal mass 
Faint/absent ephrogram 
Table I l l .  Summary of cardiac risk factors 
Risk factors (No. of patients studied) No. of patients (%) 
Clinical history (20) 
Angina 12 (60) 
MI 13 (65) 
CABG 2 (10) 
Arrythmia 8 (40) 
CHF 18 (90) 
Abnormal resting ECG (20) 
LVH 19 (95) 
LV Strain 8 (40) 
Remote MI 13 (65) 
Arrhythmia 5 (20) 
Abnormal resting echocardiography (19) 
LVEF <30% 3 (16) 
Wall motion abnormality 7 (37) 
Abnormal stress test (11) 
Exercise ECG 3 (27) 
Dobutamine echocardiogram 3 (27) 
Adenosine thallium 3 (27) 
Abnormal coronary angiogram (9) 
LVEF <-30% 2 (22) 
At least moderate CAD 7 (78) 
At least one risk factor present 20 (100) 
M/, Myocardial infarction; CABG, coronary artery bypass grafting; CHF, congestive heart failure: LVH, left ventricular hypertrophy; 
LVEF, left ventricular ejection fraction; ECG, electrocardiogram; CAD, coronary artery disease. 
Severity of nephrosclerosis. Cut-film angio- 
grams were reviewed independently b  two of the 
authors (K.J.H., S.B.F.) to grade the severity of 
nephrosclerosis a follows: 19 grade I: normal intra- 
renal vascular pattern with orderly progression of 
parenchymal branching in combination with a nor- 
real nephrogram; grade II: ectasia of arcuate and 
distal interlobar arteries with peripheral pruning and 
reduced arterial volume in combination with a 
normal nephrogram; and grade III: marked ectasia 
extending centrally with total pruning and abrupt 
interlobar terminations, and marked reduction in 
internal volume in combination with a faint or absent 
nephrography result (Table II). 
PATIENT MANAGEMENT 
Clinical presentation 
Each patient was diagnosed with significant 
hypertension i  combination with severe renal insuf- 
ficiency requiring dialysis support. In two patients, 
severe hypertension was associated with encephalop- 
athy. Eighteen patients required medical treatment 
for clinical pulmonary edema t some time during the 
3-month period before operation and eight patients 
had pulmonary edema on presentation. By echocar- 
diography, left ventricuiar systolic function was 
considered normal in 17 of these patients. Eleven 
patients required intensive care unit treatment im- 
mediately before renal artery (RA) repair, which 
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Fig. 1. Product-limil estimate of patient survival according to dialysis tatus after operation 
(n = 20) 
Table IV. Immediate and late function response versus site of disease 
Unilateral (n = 4) Bilateral (n = 16) Total (n = 20) 
Dialysis tatus No. of patients (%) No. of patients (%) No. of patients (%) 
Immediate r sult* 
Dependent 3 (75) 1 (6) 4 (20) 
Independent 1 (25) I5 (94) i6 (80) 
Late result? 
Dependent 3 (75) 3 (19) 6 (30) 
Independent I (25) 13 (81) 14 (70) 
*p = 0.01, significant a the 0.05 alpha level after controlling for multiple comparisons. 
~p = 0.06. 
included intubation and mechanical ventilation in 
three patients and treatment of serious arrhythrnias 
after cardiopulmonary arrest in one patient. 
Diagnostic evaluations 
Renal duplex sonography. Renal duplex sonog- 
raphy (RDS) was used to identify RA stenosis or 
occlusion in 11 patients before operation. By previ- 
ously validated criteria, RDS correctly identified six 
of six RA occlusions and i1 of 12 RA stenoses that 
were greater than 60% diameter educing when 
compared with subsequent conventional cut-film 
angiography, z° 
Angiography. Renal angiography was per- 
formed by use of the Seldinger method with con- 
ventional cut-film technique. Prior aortoiliac recon- 
struction in combination with unilateral RA repair 
was present in two patients. Overall, significant RA 
disease was present unilaterally in four patients and 
bilaterally in 15 patients, and one patient demon- 
strated significant disease to a solitary kidney. Disease 
was manifest by greater than 80% to 90% diameter- 
reducing renal artery stenosis in three instances, 
greater than 90% to 99% in 16 instances, and 
occlusion of 16 renal arteries. Every RA stenosis was 
aortic in origin and considered ostial. In 13 of 16 RA 
occlusions, a patent distal renal artery was demon- 
strated on delayed angiographic mages. 
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Table V. Immediate renal function response versus site of operation 
Before dialysis After operation 
No. Mean EGFR +- SD Mean EGFR -- SD 
Unilateral 4 7.23 -+ 1.78 11.53 +- 5.54 
I ' p = 0.22 a I 
p = 0.58 p =0.02  ~ 
I I 
Bilateral 16 7.83 _+ 1.89 31.41 -+ 15.68 
, p < 0 .01t  , 
~p Value NS at the 0.05 alpha level after controlling for multiple comparisons. 
Jp Value significant a the 0.05 alpha level after controlling for multiple comparisons. 
Table VI. Change in the natural og of EGFR per week before and after operation 
Entire group 
No. Mean Slope SE 
Before dialysis 
After operation 
20 -0.1000 0.0305 
I 
p = 0.02 
I 
16 - 0.0069 0.0141 
Table VII. Change in the natural og of EGFR per week versus postoperative dialysis status 
Post-operative on dialys# 
N Mean Slope +- SE N 
Post-operative off dialysis 
Mean Slope +_ SE 
Before Dialysis 
After Operation 
6 -0.0188 _+ 0.0464 14 
[ P 0.042 
p = 0.78 
I 
2 0.0002 -+ 0.0496 14 
' p = 0.87 
-0.1393 -+ 0.0340 
I 
p < 0.01t 
I 
-0.0085 +- 0.0152 
i 
~p Value NS at the 0.05 alpha level after controlling for multiple comparisons. 
tp Vlaue significant a the 0.05 alpha level after controlling for multiple comparisons. 
For 26 kidneys in 16 patients, angiograms were 
technically adequate to grade severity of nephroscle- 
rosis and presence of contrast excretion. By criteria 
already described, grade I nephrosclerosis was 
present in 4% of kidneys, grade II in 46%, and grade 
111 nephrosclerosis was considered present in 50% 
(Table II). 
Preoperative valuation 
After complete medical history, physical exami- 
nation and resting electrocardiography, each patient 
had further cardiac evaluation (Table III). These 
evaluations included resting or Dobutamine stress 
echocardiography (19 patients), stress electrocardi- 
ography (five patients), and adenosine-thallium car- 
diac imaging (three patients). Nine patients were 
studied with coronary artery angiography within 6 
months of RA surgery, resulting in coronary artery 
bypass grafting (2 patients) or balloon angioplasty 
(one patient). 
Isotopic renography was performed in 10 pa- 
tients. Six studies were uninterpretable b cause of 
extremely ow blood flow and function. EGFR from 
the remaining four studies ranged from 6.5 to 10.4 
ml/min/1.73 m 2. 
Pulmonary artery catheters were placed 12 to 24 
hours before surgery in 11 patients. The remaining 
patients had catheters placed just before operation. 
The other routine features of our perioperative 
management have been previously described. 21
Operative Procedures 
Thirty-five kidneys underwent operation. Four 
patients had unilateral RA repair, 13 patients had 
bilateral repair, and one patient had RA repair to a 
solitary kidney. Two patients had unilateral repair 
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and contralateral nephrectomy of a kidney with a 
nonreconstructible vessel (one RA occlusion; one 
stenosis). These kidneys measured 6.6 and 9.9 cm in 
length. In no instance was significant RVD left 
untreated. 
Renal revascularization was performed in each 
instance of significant RA stenosis or occlusion when 
a normal distal RA could be demonstrated at 
operation. Renal artery reconstruction i cluded aor- 
torenal bypass in 23 instances (19 saphenous vein; 4 
polytetrafluoroethylene) and thromboendarterec- 
tomy in 10 instances (6 transrenal; 4 transaortic). In 
sire branch renal artery repairs were performed to 
eight kidneys. Seven patients had simultaneous aortic 
reconstruction for correction of abdominal aortic 
aneurysm (four patients; 6.6 cm mean diameter) or 
aortic occlusion (three patients). Of these combined 
procedures, ix patients had bilateral RA repair. 
RESULTS OF OPERATION 
Postoperative morbidity and mortality 
Early events. The median period of hospitaliza- 
tion after operation was 16.5 days (range 7 to 112 
days). There were no deaths within 30 days of 
surgery; however, nonfatal postoperative morbid 
events prolonging hospital stay occurred in eight 
patients. These included serious arrhythmia (one 
patient), pneumonia (three patients), prolonged 
mechanical ventilatory support (two patients), line 
sepsis (two patients), infected hemodialysis hunt 
requiring removal (one patient), gastrointestinal 
bleeding (one patient) and chylous ascites requiring 
placement of a peritoneovenous shunt (one patient). 
Late events. There were seven deaths in this 
patient group monitored for up to 56 months with a 
mean follow-up of 22 months. Deaths resulted from 
cardiovascular-related causes in six patients (three 
myocardial infarctions; one cerebral vascular acci- 
dent; two sudden deaths presumed to be cardio- 
vascular-related in origin). Intraabdomin,'fl sepsis ac- 
counted for the single noncardiovascular-related 
death. Death on follow-up was significantly influ- 
enced by the renal function response to operation 
(Fig. 1). There were two follow-up deaths among 14 
patients not receiving dialysis (one sudden death; one 
septic death), whereas five of six patients dependent 
on dialysis died of cardiovascular-related causes 
(p < 0.01). Additionally, there were four nonfatal 
cardiovascular events on follow-up. These included a
myocardial infarction (one patient), cerebral vascular 
accidents (t~vo patients) and occlusion of a bilateral 
RA repair (one patient). Additional vascular proce- 
dures were required in three patients on follow-up. 
Fig. 2. Preoperative aortogram demonstrates bilatera! 
renal artery occlusion (A) with late RA reconstimtion (B). 
Postoperative aortogram (C) after bilateral thromboend- 
arterectomy and removal from dialysis dependence. 
These included acarotid endarterectomy, a corona U
artery bypass grafting, and a surgical thrombectomy 
of bilateral RA bypass grafts. Finally-, one patient 
required anephrectomy for renal cell carcinoma dis- 
covered uring follow-up RDS 2 years after RA re- 
pairs for bilateral occlusion. A left radical nephrec- 
tomy was performed, and the patient has discontin- 
ued receiving dialysis (last creatinine: 2.4 mg/dl) and 
has remained free of malignant disease. 
Patency of renovascular reconstruction during 
follow-up was determined by angiography (6 pa- 
tients) or RDS (10 patients) defining the status of 20 
RA repairs (Fig. 2). Two months after operation, a
patient in whom dialysis was initially discontinued 
had bilateral RA bypass grafts hrombose. After 1 
week of dialysis support, graft thrombectomies were 
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Fig. 3. Graphic depiction ofpreoperative and postoperative percent decline in EGFR per week 
for all 20 patients. Note immediate improvement i  EGFR and significant improvement i  rate 
of decline in EGFR after operation. 
Table VIII. Correlation between immediate change in EGFR and selected preoperative parameters 
Mean SD Min Max Correlation (95% CI) 
Severity of nephrosclerosis (grade) 2.47 0.50 
Severity of renal artery stenosis (%) 90.9 12.8 
Renal ength (cm) 9.56 1.07 
Preoperative slope -0.100 0.118 
[log¢(ml/min/1.73 m2)/wk] 
1.0 3.0 -0.57* (-0.83, -0.10) 
60 100 0.301- (-0.16, 0.66) 
6.6 12.0 0.331- (-0.13, 0.67) 
-0.532 -0.003 -0.591- (-0.82, -0.19) 
*Rank correlation. 
1-Pearson product-moment correlation. 
performed, and dialysis was discontinued a second 
time. 
Renal function response 
Three weeks after operation, dialysis was discon- 
tinued in 16 of 20 patients (Table IV). Two patients 
in whom dialysis was discontinued immediately after 
surgery resumed undergoing dialysis 4 and 8 months 
later. Each patient demonstrated a small immediate 
increase in EGFR (3.1 and 4.4 ml/min/1.73 m2). 
These two patients and the four patients dependent 
on dialysis immediately after surgery had the patency 
of RA repair confirmed by RDS or angiography. A 
third patient not receiving dialysis had thrombosis of 
bilateral renal artery bypass grafts 2 months after 
operation. After reoperation, dialysis was discontin- 
ued in this patient a second time. 
To examine the immediate function response to 
RA repair, the last predialysis EGFR was used for 
both preoperative and postoperative EGFR values in 
the four patients who continued to receive dialysis. 
For the entire group of 20 patients, the mean im- 
mediate increase in EGFR was significant (mean _+ 
SD: 19.7 m 15.5 ml/min/1.73 m2;p < 0.01). 
Dialysis status and immediate increase in EGFR 
after operation was influenced by the site of disease 
and operation (Tables IV and V). For purposes of 
analysis, revascularization f a solitary kidney and 
unilateral RA repair with contralateral nephrectorny 
were considered with bilateral operations. Consider- 
ing patient dialysis tatus 3 weeks after operation, 15 
of 16 patients were not receiving dialysis after 
bilateral repair compared with only 1 of 4 patients 
after unilateral repair (p < 0.01). Patients undergo- 
ing bilateral RA repair had an increase in EGFR 
(mean change in EGFR: 22.6 _+ 14.8. ml/min/I.73 
m 2) compared with patients after unilateral repair 
(mean change in EGFR: 4.3 + 5.5 ml/min/1.73 m2; 
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Fig. 4. Graphic depiction of preoperative and postoperative p rcent decline in EGFR per week 
for patients not receiving dialysis (solid line, n = 14) and patients receiving dialysis (broken line, 
n = 6) after surgery. (*Difference between preoperative and postoperative slopes in patients not 
dependent on dialysis after operation is significant after controlling for multiple comparisons; 
+Difference in preoperative slopes between patients dependent and not dependent on dialysis 
after operation is not significant after controlling for multiple comparisons.) 
p = 0.02, but NS after controlling for multiple 
comparisons). 
Tables VI and VII compare the rates of change in 
EGFR before and after operation. Considering all 20 
patients before operation and the 16 patients initially 
removed from dialysis, the average rate of decline in 
EGFR before operation was significantly greater than 
the decline after surgery (p = 0.02). These data are 
depicted graphically in Fig. 3. The average rate of 
decline per week in the natural og of EGFR before 
operation was greater among patients in whom dialy- 
sis was permanently discontinued (n = 14; mean 
slope + SE: -0 .1393 _+ 0.0340)as compared with 
patients who were dependent on dialysis on follow- 
up (n = 6; mean slope _ SE: -0 .0188 _ 0.0464; 
p = 0.04, but NS after controlling for multiple com- 
parisons). These data are depicted graphically in Fig. 
4. Finally, the rate of change in EGFR for these 20 
patients dependent on dialysis is compared graphi- 
cally with 53 patients with non-dialysis-dependent 
azotemia in Fig. 5. Patients dependent on dialysis 
demonstrated a greater ate of decline in EGFR be- 
fore operation (slope +_ SE: 0.1000 _ 0.0305 dialy- 
sis dependence and -0 .0216 +_ 0.0056 for dialysis 
independence, p = 0.01). Both the EGFR and file 
rate of change in EGFR after operation, however, 
were similar for both patient groups (slope +_ SE: 
-0 .0069 + 0.0141 and -0 .0048 _+ 0.0039 for di- 
alysis dependence and independence, respectively, 
p = 0.89). 
Analysis of immediate function response after op- 
eration demonstrated no apparent association with 
the severity of renal artery stenosis, preoperative r nal 
length, or extent of extrarenal atherosclerosis (Table 
VIII). However, in 16 patients for whom preopera- 
tive angiograms were available for evaluation, an in- 
verse correlation was found between the severity of 
nephrosclerosis and the immediate change in EGFR 
(rank correlation: - 0.57; 95% CI [ - 0.83, - 0.10]). 
DISCUSSION 
Is dialysis-dependent ischemic nephropathy a 
clinical curiosity limited to a few centers with a special 
interest in renovascular disease or is it an underrec- 
ognized contzibutor to ESRD? Unfortunately com- 
plete data to answer this question are lacking. 
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Fig. 5. Graphic depiction of preoperative and postoperative p rcent decline in EGFR per week 
for patients dependent on dialysis (solid line, n = 20) and not dependent on dialysis (broken line, 
n = 53) before operation. (*Difference inpreoperative slopes between subjects not receiving 
and receiving preoperative dialysis is significant after controlling for multiple comparisons.) 
However, available information suggests that unsus- 
pected hemodynamically significant RVD is preva- 
lent in the atherosclerotic population, and this 
prevalence increases with increasing age) When 
present, atherosclerotic RVD is bilateral in roughly 
half of subjects and frequently demonstrates ana- 
tomic progression over time. 22,23 Progression to a 
higher degree of stenosis or occlusion is often 
associated with a decrease inkidney size and a decline 
in renal excretory function irrespective of the quality 
of hypertension contro l .  4'24-26 These features of 
prevalent RVD anatomically progressive and fie- 
quently associated with a rapid decline in renal 
function suggest that ischemic nephropathy may be a 
more important cause of renal insufficiency in the 
atherosclerotic population than is commonly recog- 
nized.l,2, 7 
This view is also supported by the demography of 
patients currently progressing to ESRD. Data from 
the North Carolina Kidney Council demonstrate that 
73% of patients progressing toESRD are 50 years of 
age or older. 28 From these same data, 50% of patients 
with ESRD from our state have hypertension asthe 
presumed cause. Patients with these demographic 
features have been recently studied by Scoble et al. a,s 
These investigators performed angiography in pa- 
tients evaluated for renal replacement therapy, who 
met criteria of either significant hypertension, asym- 
metric kidney size, unexplained kidney failure, or 
systemic atherosclerotic disease. Significant RVD 
was present in 6% of patients overall and 14% of 
patients over the age of 50 years. 
Applying the premise that significant RVD is 
prevalent in the atherosclerotic population and may 
cause excretory renal insufficiency, which can 
progress to ESRD and dialysis dependence, we 
currently screen for ischemic nephropathy in all 
patients with hypertension ver the age of 50 years 
diagnosed with newly recognized renal insuffi- 
ciency. 21- Our preferred screening method is RDS, a 
technique that has demonstrated anoverall accuracy 
of 96% compared with conventional ngiography for 
60% or greater diameter-reducing main renal artery 
stenosis or occlusion. 2° We have used RDS to screen 
randomly selected patients from the Section on 
Nephrology clinic files. 29 Patients 45 to 75 years of 
age with serum creatinine of 2.0 mg/dl or greater and 
no known history of RVD were considered for 
screening. Among 21 patients selected for RDS 
examination, three patients (14%) demonstrated 
unsuspected RVD. Moreover, during the past 14 
months, we have screened all patients with new-onset 
ESRD considered for renal replacement therapy. 
Nine of 42 consecutive patients (21%) over the age 
of 50 years have demonstrated RVD by renal duplex 
sonography. 3° 
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Once dia!ysis-dependent ischemic nephropathy is 
identified, most issues regarding anticipated function 
retrieval in a particular patient remain poorly de- 
fined. 4'21'a1'32 In this study, we observed that the site 
of disease and operation and the rate of decline in 
preoperative EGFR differed between patients in 
whom dialysis was discontinued and those whose 
conditions were unimproved after operation. Al- 
though nephrosclerosis was inversely correlated with 
change in EGFR after operation, severity of neph- 
rosclerosis did not differ significantly between pa- 
tients receiving and not receiving dialysis. In particu- 
lar, the role of repair of unilateral RVD in patients 
with renal insufficiency of any degree is uncertain. In 
this regard, we recently reviewed our operative 
experience in 70 patients with non-dialysis- 
dependent ischemic nephropathy. 2~ A significant 
increase in EGFR was observed in patients who 
underwent bilateral but not unilateral RA repair. 
When individual patients were considered, however, 
one third demonstrated at least a 20% increase in 
EGFR after unilateral repair-a rate comparable to 
the function response after unilateral repair observed 
in this report. 
Even greater uncertainty surrounds the role of 
renal artery repair in the patient who has normal 
blood pressure with renal insufficiency. In this 
instance, the issue is whether RVD sufficient to cause 
lddney failure can exist without raising blood pres- 
sure. This clinical scenario has the greatest practical 
importance ~+br the patient who has normal blood 
pressure as a consequence of antihypertensive agents. 
In the setting of RVD, the contribution of potent 
diuretics and angiotensin-converting e zyme inhibi- 
tors to renal dysfunction is widely recognized. 
Otherwise, in the complete absence of hypertension, 
the physiologic importance of RVD as a cause of 
renal insufficiency must remain suspect. ~Despite 
this, a few authors have recommended prophylactic 
correction of RVD before the onset of either 
hypertension r renal insufficiency to preserve future 
renal function. 33 We disagree with this clinical 
strategy for two reasons. First, based on available data 
regarding progression of silent anatomic lesions to 
clinical significance compared with the rates of 
function decline and function retrieval in the setting 
of renovascular hypertension, we estimate that less 
than 5% of patients with clinically silent RVD would 
be uniquely benefitted by prophylactic ntervention. 
This rate of unique benefit is equalled or exceeded by 
the risk of adverse surgical outcome in this patient 
population. 34 Second, available data regarding 
EGFR before and after operation fall to support he 
notion of RA repair to "preserve" renal function. Our 
analysis of patients with non-dialysis-dependent isch-
emic nephropathy suggests that only those patients 
who demonstrate incremental improvement in renal 
function immediately after operation experience a 
decrease in subsequent rate of decline in EGFR. 4 
Furthermore, only those patients with immediate 
improvement in renal function and decreased decline 
in EGFR after surgery demonstrate a reduced risk of 
progression toESRD and dialysis dependence. These 
data suggest that, after correction of RVD, patients 
are returned to a rate of decline in renal function, 
which may be characteristic for this atherosclerotic 
age group. Patients whose renal functions are not 
significantly improved after surge U are probably 
unchanged and not protected from ESRD failure by 
virtue of renovascular repair. 
In the absence of accurate predictors of renal 
function response to operation, our lack of preop- 
erative and intraoperative renal biopsy material 
deserves comment. Previous reports have indicated 
that renal revascularization can be guided by a 
"well-selected and representative" renal biopsy. 3s 
When at least 70% of glomeruli appear viable on 
biopsy, improvement in excretory function after 
revascularization has been suggested. By contrast, we 
no longer perform routine renal biopsy on the 
premise that glomerular obsolescence and hyahniza- 
tion can be a focal process. Our view is that 
normal-appearing glomerular architecture on biopsy 
may support an increased chance for function 
retrieval; however, glomerular obsolescence oneither 
wedge or needle biopsy does not preclude beneficial 
function response. This point is emphasized by the 
single patient in this series who underwent a percu- 
taneous renal biopsy before surgery (Fig. 6). On the 
basis of glomerular obsolescence in over half of 
glomeruli, anonoperative approach ad been advised 
at another center. After operation, dialysis was 
permanently discontinued in this patient (Fig. 3), 
Finally, survival estimates for patients with 
dialysis-dependent ischemic nephropathy confirm as~ 
increased rate of death on follow-up when compared 
with patients with atherosclerosis treated for reno- 
vascular hypertension without renal insuNciency, 
Specifically, pauents with dialysis-dependent isch- 
emic nephropathy who remain dependent on dialysis 
after operation demonstrated an extremely rapid rate 
of death. Although rapid, the observed rate of death 
for these elderly patients with atherosclerosis i  
consistent with the experience ofothers and approxi- 
mates mortality rates observed for patients with 
ischemic nephropathy and ESRD who did not 
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Fig. 6. Photomicrographs (Original magnification × 25) ofpercutaneous renal biopsies taken 
before operation. Glomerular obsolescence (A) is demonstrated in more than half of glomeruli 
present. Remaining lomeruli (B) demonstrated ischemic collapse with focal and segmental 
sclerosis. Dialysis was discontinued in this patient after operation. 
undergo operation, a 36,a7 By contrast, he estimated 
survival rate for patients dependent on dialysis in 
whom dialysis was permanently discontinued after 
operation appears ignificantly improved and very 
similar to estimated survival rates for patients after 
operative correction of RVD and non-dialysis- 
dependent renal insufficiency. 4,38 
The experience described in this report, combined 
with our experience with non-dialysis-dependent 
kidney failure, increases our enthusiasm for further 
study of ischemic nephropathy. To define the actual 
contribution of RVD to renal insufficiency including 
ESRD, however, population-based studies defining 
the prevalence and natural history of ischemic 
nephropathy are needed. Even though data suggest 
that ischemic nephropathy may contribute to pro- 
gressive kidney failure associated with an increased 
rate of cardiovascular death, whether enovascular 
repair in this setting would decrease the rate of renal 
function decline and postpone dialysis or prolong 
survival compared with medical management is
unknown. Clarification of these issues requires a 
well-controlled, prospective, randomized, clinical 
trial. Such a trial would require multicenter partici- 
pation to compare interventional treatment plus 
medical management versus medical management 
alone in patients with ischemic nephropathy and 
renal insufficiency of all degrees, including dialysis 
dependence. 
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DISCUSSION 
Dr. Walter M. Whitehouse, Jr. (Ann Arbor, Mich.). 
Dr. Hansen and his colleagues have presented a thorough 
and thoughtful retrospective analysis of their experience 
with renal artery reconstruction in patients who are 
dependent on dialysis as a result of ischemic nephropathy. 
This indeed represents a large experience of consecutive 
patients undergoing surgical therapy. These patients rep- 
resent asubset of those with vascular disease who would be 
considered at very high surgical risk under any circum- 
stances. These results are excellent. There were no operative 
deaths. Response to operation was notable both from a 
perspective ofretrieval of renal function and blood pressure 
control. After renal artery reconstruction, 80% of patients 
were removed from dialysis at 3 weeks. Two of these 
patients resumed long-term hemodialysis at 4 and 8 
months. Nonetheless, 14 of 20 patients remained ialysis 
free on long-term follow-up averaging 2 years. Analysis of 
those results uggests that patients who were most likely to 
respond were those with rapid preoperative decline of 
EGFR. An 86% long-term survival rate was noted in 
patients not requiring dialysis, whereas patients who 
remained ependent on dialysis had a very poor survival 
rate. Of course a more meaningful statistical correlation 
would be comparing those who were dialysis free with 
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those who had not undergone operation and were still 
dependent on dialysis. 
The operative results and survival results are admirable 
and certainly stimulate additional consideration of a more 
aggressive surgical approach in this group of patients. 
What were the specific indications for operation in this 
group of patients? Were any factors considered to be 
absolute contraindications to exclude patients from opera- 
tive intervention? One would have to assume that the 
excellent results reported are, in part, a reflection of careful 
and precise patient selection. Do you and your nephrolo- 
gists at this time have an ongoing protocol for screening of 
patients as they enter this dialysis population? Patients 
reported in this series were receiving dialysis for relatively 
short periods of time, ranging from 1 to 9 weeks. Some of 
us have had the experience of performing revascularization 
on patients who have been dependent on dialysis for longer 
periods of time with subsequent return of renal function 
after operation. The incidence of diabetes was quite low in 
this group of patients, approximately 15%. Mthough it's 
not specifically mentioned, I wonder if the presence of 
diabetes correlated at all with a lack of improvement after 
arterial reconstruction. 
The patients presented by the authors represent a very 
challenging roup with severe xtrarenal vascular disease. It 
is interesting to note that successful revascularization was 
possible with standard irect aortorenal reconstruction i
all patients. Mthough several aortic reconstructions were 
performed, they were not performed to create an origin for 
bypass grafts. Would you comment on your philosophy 
regarding splenorenal, hepatorenal, and supraceliac aorto- 
renal bypasses in this setting. Extensive aortic disease in 
some of these patients makes direct reconstruction less 
feasible. What role do interventional techniques have to 
play in this setting? 
Finally, a certain note of caution is appropriate. This 
series with admirable results is presented by a group who 
has a long-standing history of excellence in the surgical 
treatment of renovascular hypertension, as well as a 
long-standing interest in ischemic nephropathy. It would 
be too early to generalize these results and apply them to 
every dialysis population. Certainly, these data strongly 
support detailed prospective investigation of this challeng- 
ing group of patients. Analysis of comparative survival will 
be very important in this regard. 
Dr. Kimberley J. Hansen. Although it's true that we 
do not have a group of unoperated patients, there are 
groups of patients that have not been operated on that have 
dialysis-dependent ischemic nephropathy. The survival in 
those patient groups reported by the Cleveland Clinic are 
extremely poor, with median survival of just over 8 months. 
I think that's consistent with the survival of those patients 
not removed from dialysis dependence with operation for 
ischemic nephropathy. All of these patients were evaluated 
for severe hypertension and rapidly progressing renal 
insufficiency. In no instance was a patient refused surgery 
on the basis of their concurrent heart disease, and most of 
these patients had serious comorbid cardiovascular dis- 
eases. 
The screening test of choice in our institution is renal 
duplex sonography. The test is excellent for main renal 
artery stenosis or occlusion and avoids the exposure to 
contrast in the patient in the azotemic non-dialysis- 
dependent group. 
It's impossible to define the lower limit of renal retrieval 
for the individual patient or the maximum time on dialysis 
after retrieval cannot be recognized. The longest period of 
dialysis dependence in this group is 9 weeks. Our basic 
philosophy is not to rush these patients to the operating 
room but to prepare them thoroughly from a cardiovas- 
cular standpoint, feeling that many of the issues that decide 
retrieval of renal function have been predetermined. 
It is quite likely that selection bias played a role in the 
absence of diabetic patients in this group. Those patients 
with heavy proteinuria were likely selected out of this 
patient group by our referring nephrologists. 
Our basic philosophy regarding revascularization is a 
preference for aortorenal reconstruction. In the 340 
patients who underwent operation during the same time 
period, 478 renal artery repairs were performed, and 98% 
of those were by a direct method of reconstruction. In part, 
this preference is secondary to the demography of our 
patient population. Half of our patients require bilateral 
renal artery repair; a third require concomitant aortic 
reconstruction; and a third have visceral artery disease, so 
that iliorenal bypass and splanchnorenal bypass are not 
valid alternatives. 
Unlike many institutions, we have not had a very good 
experience with either orificial atherosclerosis or the 
occluded renal artery treated by percutaneous transluminal 
angioplasty. In our experience with orificial atherosclerosis, 
the immediate and 6-month patency rates are 20% or less. 
Dr. William J. Quifiones-Baldrich (Los Angeles, 
Calif.). I think this is an extremely important subject. One 
of the problems that we face at our institution is that the 
great majority of these patients are first seen by the 
nephrologists when they are referred for dialysis, and even 
though we've tried to encourage them to use duplex 
scanning in some of these patients, it's very difficult and not 
very cost-effective to perform scanning on everybody. 
I wonder if you could expand and tell us which patients 
for whom you would recommend uplex scanning and 
what findings on duplex scanning would lead you to do 
arteriography. 
Second, could you expand on the staging of the 
nephrosclerosis based on arteriographic findings? It seems 
as if that was one of the important correlates in terms of 
obtaining good resuks with intervention. 
Dr. Hansen. The screening selection that we have used 
is to screen all new patients in the atherosclerotic age range 
who are dependent on dialysis and who have hypertension 
of any degree. We've recently screened 33 consecutive 
patients over the age of 50, and live of these had ischemic 
nephropathy. Patients in the atherosclerotic age range with 
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hypertension fany degree should undergo screening. The 
cost for duplex sonography in our institution is less than 
$300; the cost for annual renal replacement therapy is 
$45,000. 
The grading for nephrosclerosis is based on the degree 
of central vascular ectasia, the degree of peripheral pruning, 
renal mass, and the presence ofa nephrogram. This has not 
been validated by histologic measures, but it's encouraging 
that it was inversely correlated with immediate increase in 
EGFR. I would hasten to add that it was not predictive, 
though, of dialysis status after operation. 
Dr. Sven E. Bergentz (Malta6, Sweden). I want to 
point out that data from Sweden and England seem to 
indicate that about 15% of the dialysis population above 50 
years of age have an ischemic nephropathy asthe cause of 
their dialysis. 
We and others have pointed out that some of these 
patients have a very pronounced fluid retention causing 
pulmonary edema. The symptoms are often misinter- 
preted as cardiac insufficiency and are very difficult to 
diagnose. Have you had any experience with this type of 
patients ? 
Dr. Hansen. Yes, we have. Eighteen of these patients 
had pulmonary edema within 3 months of their operation. 
Only three patients had impaired systolic left ventricular 
function. I think that they fit very nicely with the group of 
patients that you've described with recurrent pulmonary 
edema. 
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